Overview:

Summary

GlobalData’s new report, “Cochlear Limited Market Share Analysis” provides in-depth information on Cochlear Limited’s market position in the hearing implants market. The report also provides data and information on the overall competitive landscape within the hearing implants market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the hearing implants market.
- Cochlear Limited’s company shares (in Revenues) information for all the key countries the company has presence in – India, Japan, China, Australia, United Kingdom, France, Germany, Spain, Italy, United States, Canada and Brazil.
- Cochlear Limited’s company shares (in Revenues) information for the hearing implants market.
- All the key data-points are for 2010 and cover all the key regions – North America, Middle East and Africa, Europe, Asia-Pacific and South and Central America.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Cochlear Limited’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Cochlear Limited’s market positions."

Companies Mentioned

Advanced Bionics Corporation
Envoy Medical Corporation
MED-EL
Neurelec
Sonova Holding AG
William Demant Holding A/S

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets/Categories Covered 10
3.1 Hearing Implants 10
4 Company Snapshot 11
4.1 Key Information 11
4.2 Company Overview 11
4.3 Financial Performance 11
4.4 SWOT Snapshot 11
5 Business Description 12
5.1 Business Overview 12
5.2 Implantable Hearing Devices 12
5.2.1 Overview 12
5.2.2 Financials 12
5.2.3 Market View 12
5.2.4 Key Strategies 12
5.3 Major Products and Services 13
5.3.1 Overview 13
6 History 14
7 Business Strategy 18
7.1 Mission Statement 18
8 SWOT Analysis 18
8.1 Overview 18
8.2 Cochlear Limited Strengths 19
8.2.1 Expanding Market Share in the Sector 19
8.2.2 Diversified Geographic Presence 19
8.2.3 Focused Research and Development Activities 19
8.3 Cochlear Limited Weaknesses 20
8.3.1 Government Investigation 20
8.3.2 Decline in Liquidity Ratios 20
8.3.3 Patent Infringement Claims 20
8.4 Cochlear Limited Opportunities 20
8.4.1 Global ENT Devices Market 20
8.4.2 Growing Aged Population 21
8.4.3 Building Regional Infrastructure 21
8.4.4 Product Expansion 21
8.5 Cochlear Limited Threats 22
8.5.1 Stringent Regulations 22
8.5.2 Inherent Market Factor 22
8.5.3 Technological Developments 22
9 Competitors 23
10 Competitive Landscape 24
10.1 Hearing Implants, Global, Market Share (%), 2010 24
11 Cochlear Limited Medical Equipment Market Share Analysis 25
11.1 Cochlear Limited, Hearing Implants, Global, Market Share (2010) 25
11.2 Cochlear Limited, Asia-Pacific, Market Share (2010) 26
11.3 Cochlear Limited, Europe, Market Share (2010) 27
11.4 Cochlear Limited, Middle East and Africa, Market Share (2010) 28
11.5 Cochlear Limited, North America, Market Share (2010) 29
11.6 Cochlear Limited, South and Central America, Market Share (2010) 30
12 Share Holding Structure 31
13 Key Employees 32
14 Key Employee Biographies 33
15 Company Statement 34
16 Locations And Subsidiaries 36
16.1 Head Office 36
16.2 Other Locations & Subsidiaries 36
17 Financial Deals Landscape 38
17.1 Cochlear Limited, Deals Volume Summary, 2006 to YTD 2011 38
18 Cochlear Limited Detailed Deal Summary 40
18.1 Asset Purchase 40
18.1.1 Cochlear To Acquire Technology Rights From Otologics 40
18.2 Acquisition 41
18.2.1 Cochlear Acquires Entific From Nobel Biocare, CapMan And Investor Growth Capital 41
19 Recent Developments 43
19.1 Strategy and Business Planning 43
19.1.1 Aug 13, 2010: Cochlear Sets Up New Subsidiary In India 43
19.1.2 Oct 14, 2009: Cochlear And NXP Collaborate To Enable Cochlear’s Next Generation Hearing Implant Products 43
19.1.3 Jun 03, 2009: Cochlear Announces Conclusion Of Agreements For New Global Headquarters 43
19.2 Financial Announcements 44
19.2.1 Feb 08, 2011: Cochlear Reports H1 Fiscal Year Ended 2011 Results 44
19.2.2 Aug 10, 2010: Cochlear Reports Total Revenue Of AUD734.8m In Fiscal Year Ended 2010 44
19.2.3 Feb 09, 2010: Cochlear Reports H1 Fiscal Year Ended 2010 Results 45
19.2.4 Aug 11, 2009: Cochlear Reports Total Revenues Of AUD694.7 Million For Fiscal 2009 46
19.2.5 Jul 13, 2009: Cochlear Provides Guidance For Fiscal 2009 48
19.2.6 Feb 10, 2009: Cochlear Reports H1 Fiscal 2009 Results 49
19.2.7 Aug 12, 2008: Cochlear Reports Fiscal 2008 Results 51
19.2.8 Feb 12, 2008: Cochlear Reports H1 Fiscal 2008 Results 53
19.2.9 Aug 14, 2007: Cochlear Declares Final Dividend 55
19.2.10 Aug 14, 2007: Cochlear Reports Fiscal 2007 Results 55
19.2.11 Feb 13, 2007: Cochlear Reports H1 Fiscal 2007 Results 56
19.2.12 Aug 15, 2006: Cochlear Reports Fiscal 2006 Results 56
19.3 Corporate Communications 56
19.3.1 Aug 02, 2010: Cochlear Appoints Yasmin Allen As Non-Executive Director 56
19.3.2 Mar 17, 2010: Cochlear Announces Retirement Of Tommie Bergman As Chairman And Non-Executive Director 56
19.3.3 Dec 15, 2006: Cochlear Appoints New Board Member 57
19.3.4 Jul 18, 2006: Cochlear Board Members To Retire 57
19.4 Product News 58
19.4.1 Mar 29, 2010: Cochlear To Complete Clinical Trial For Cochlear Nucleus 5 In First Quarter Of 2012 58
19.4.2 Sep 04, 2009: Cochlear Announces FDA Approval For Cochlear Nucleus 5 System 58
19.4.3 Jul 10, 2009: Cochlear Americas Receives US FDA Clearance For Cochlear Baha BP100 Sound Processor 58
19.4.4 Jul 25, 2008: Cochlear Announces Milestone In Hearing Restoration With 120,000 Nucleus Cochlear Implants 59
19.5 Product Approvals 59
19.5.1 Sep 04, 2009: Cochlear Announces FDA Approval For Cochlear Nucleus 5 System 59
19.5.2 Jul 10, 2009: Cochlear Americas Receives US FDA Clearance For Cochlear Baha BP100 Sound Processor 59
19.6 Clinical Trials 60
19.6.1 Mar 29, 2010: Cochlear To Complete Clinical Trial For Cochlear Nucleus 5 In First Quarter Of 2012 60
19.7 Other Significant Developments 60
19.7.1 Jul 11, 2010: Cochlear To Spend $15 Million Over Five Years In India 60
19.7.2 Jun 03, 2009: Watpac bags Cochlear headquarters project in Australia 61
20 Appendix 62
20.1 Research Methodology 63
20.2 Secondary Research 63
20.3 Primary Research 64
20.4 Models 64
20.5 Forecasts 65
20.6 Expert Panels 65
20.7 GlobalData Consulting 65
20.8 Currency Conversion 66
20.9 Contact Us 67
20.10 Disclaimer 67"

1.1 List of Tables
Table 1:      Cochlear Limited, Key Facts, 2010 11
Table 2:      Cochlear Limited, SWOT Analysis, 2010 18
Table 3: Hearing Implants, Global, Company Share by Revenue ($m), 2010 24
Table 4:      Cochlear Limited, Hearing Implants, Global, Revenue ($m) and Market Share (%), 2010 25
Table 5:      Cochlear Limited, Hearing Implants, Asia-Pacific, Revenue ($m) and Market Share (%), 2010 26
Table 6:      Cochlear Limited, Hearing Implants, Europe, Revenue ($m) and Market Share (%), 2010 27
Table 7:      Cochlear Limited, Hearing Implants, Middle East and Africa, Revenue ($m) and Market Share (%), 2010 28
Table 8:      Cochlear Limited, Hearing Implants, North America, Revenue ($m) and Market Share (%), 2010 29
Table 9:      Cochlear Limited, Hearing Implants, South and Central America, Revenue ($m) and Market Share (%), 2010 30
Table 10:      Cochlear Limited, Share Holding Structure 31
Table 11:      Cochlear Limited, Key Employees 32
Table 12:      Cochlear Limited, Other Locations 36
Table 13:      Cochlear Limited, Subsidiaries 36
Table 14:      Cochlear Limited, Deals Volume Summary, 2006 to YTD 2011 38
Table 15:      Cochlear Limited, Deals Summary, 2006 to YTD 2011 39
Table 16:      Cochlear To Acquire Technology Rights From Otologics 40
Table 17:      Cochlear Acquires Entific From Nobel Biocare, CapMan And Investor Growth Capital 41
Table 18:   USD to Local Currency, Average Exchange Rate, 2010 66"

1.2 List of Figures
Figure 1:      Hearing Implants, Global, Market Share (%), 2010 24
Figure 2:      Cochlear Limited, Hearing Implants, Global, Market Share (%), 2010 25
Figure 3:      Cochlear Limited, Hearing Implants, Asia-Pacific, Market Share (%), 2010 26
Figure 4:      Cochlear Limited, Hearing Implants, Europe, Market Share (%), 2010 27
Figure 5:      Cochlear Limited, Hearing Implants, North America, Market Share (%), 2010 29
Figure 6:      Cochlear Limited, Hearing Implants, South and Central America, Market Share (%), 2010 30
Figure 7:      Cochlear Limited, Deals Volume Summary, 2006 to YTD 2011 38